Diagnosis and Treatment Strategy of Recurrent Spontaneous Abortion Associated With Thrombophilla

Last updated: December 8, 2016
Sponsor: Shanghai First Maternity and Infant Hospital
Overall Status: Trial Status Unknown

Phase

4

Condition

Blood Clots

Thrombosis

Treatment

N/A

Clinical Study ID

NCT02986594
ShanghaiFIMH-0002
  • Ages 18-50
  • Female

Study Summary

In this clinical cohort study, the investigators observe the efficacy of low molecular weight heparin in the treatment of thrombophilia with recurrent pregnancy loss with a prospective randomized controlled trial.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Woman who had their Second miscarriage before 12(th) week of gestation.The patient whois diagnosed as thrombophilia with recurrent pregnancy loss. Signed consent form.

Exclusion

Exclusion Criteria:

  1. having experiencedsevere allergies, trauma history and/or operation history within 3months

  2. with a history of mental illness and/or family history of mental illness

  3. limb disabled

  4. taking medicine within one month

  5. suffering major events or having mood swings

  6. with a history of recurrent pregnancy loss

  7. having internal and surgical disease(after having variety of physical examination suchas electrocardiogram/hepatic and renal function/blood routine and urine rotine)

  8. Chromosome aberrations in anyone of the couple.

  9. patients who have drug contraindications

Study Design

Total Participants: 600
Study Start date:
November 01, 2016
Estimated Completion Date:
October 31, 2019

Connect with a study center

  • Shanghai first Maternity and Infant health hospital, Tong Ji University

    Shanghai, 200051
    China

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.